Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis

Gut

Volumn 57, Issue 4, 2008, Pages 463-467

  Wapenaar, M C ^a,b   Monsuur, A J ^a   Van Bodegraven, A A ^c   Weersma, R K ^b   Bevova, M R ^a   Linskens, R K ^d   Howdle, P ^e   Holmes, G ^f   Mulder, C J ^c   Dijkstra, G ^b   Van Heel, D A ^g   Wijmenga, C ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ST ANNA HOSPITAL   (Netherlands)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^f DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

^g QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CELIAC DISEASE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; ENTERITIS; GENE; GENE REPLICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTESTINE EPITHELIUM; INTESTINE MUCOSA PERMEABILITY; MAGI2 GENE; MAJOR CLINICAL STUDY; NETHERLANDS; PARD3 GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TIGHT JUNCTION; ULCERATIVE COLITIS; CLINICAL TRIAL; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METHODOLOGY; MULTICENTER STUDY; PATHOPHYSIOLOGY;

AIP1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; MEMBRANE PROTEIN; PARD3 PROTEIN, HUMAN; PROTEIN; UNCLASSIFIED DRUG;

CELIAC DISEASE; CELL CYCLE PROTEINS; COHORT STUDIES; COLITIS, ULCERATIVE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MEMBRANE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; TIGHT JUNCTIONS;

EID: 41149135384     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.133132     Document Type: Article

References (40)

1. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases. Nat Clin Pract Gastroenterol Hepatol 2005;2:416-22.
2. Schreiber S, Rosenstiel P, Albrecht M, et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet 2005;6:376-88.
3. Halme L, Paavola-Sakki P, Turunen U, et al. Family and twin studies in inflammatory bowel disease. World J Gastroenterol 2006;12:3668-72.
4. Ma TY. Intestinal epithelial barrier dysfunction in Crohn's disease. Proc Soc Exp Biol Med 1997;214:318-27.
5. Sugawara K, Olson TS, Moskaluk CA, et al. Linkage to peroxisome proliferator-activated receptor-gamma in SAMP1/YitFc mice and in human Crohn's disease. Gastroenterology 2005;128:351-60.
6. Schulzke JD, Schulzke I, Fromm M, et al. Epithelial barrier and ion transport in coeliac sprue: electrical measurements on intestinal aspiration biopsy specimens. Gut 1995;37:777-82.
7. Hall EJ, Batt RM. Abnormal permeability precedes the development of a gluten sensitive enteropathy in Irish setter dogs. Gut 1991;32:749-53.
8. Smecuol E, Sugai E, Niveloni S, et al. Permeability, zonulin production, and enteropathy in dermatitis herpetiformis. Clin Gastroenterol Hepatol 2005;3:335-41.
9. Soderholm JD, Olaison G, Peterson KH, et al. Augmented increase in tight junction permeability by luminal stimuli in the non-inflamed ileum of Crohn's disease. Gut 2002;50:307-13.
10. Ciccocioppo R, Finamore A, Ara C, et al. Altered expression, localization, and phosphorylation of epithelial junctional proteins in celiac disease. Am J Clin Pathol 2006;125:502-11.
11. Newman B, Siminovitch KA. Recent advances in the genetics of inflammatory bowel disease. Curr Opin Gastroenterol 2005;21:401-7.
12. van Heel DA, Hunt K, Greco L, et al. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol 2005;19:323-39.
13. Curley CR, Monsuur AJ, Wapenaar MC, et al. A functional candidate screen for coeliac disease genes. Eur J Hum Genet 2006;14:1215-22.
14. Cottone M, Marrone C, Casa A, et al. Familial occurrence of inflammatory bowel disease in celiac disease. Inflamm Bowel Dis 2003;9:321-3.
15. Schedel J, Rockmann F, Bongartz T, et al. Association of Crohn's disease and latent celiac disease: a case report and review of the literature. Int J Colorectal Dis 2005;20:376-80.
16. Tursi A, Giorgetti GM, Brandimarte G, et al. High prevalence of celiac disease among patients affected by Crohn's disease. Inflamm Bowel Dis 2005;11:662-6.
17. Yang A, Chen Y, Scherl E, et al. Inflammatory bowel disease in patients with celiac disease. Inflamm Bowel Dis 2005;11:528- 32.
18. Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Genet 2003;4:225-36.
19. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Gastrointest Liver Physiol 2004;286:C1213- 28.
20. Monsuur AJ, de Bakker PI, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341-4.
21. Hunt KA, Monsuur AJ, McArdle WL, et al. Lack of association of MYO9B genetic variants with coeliac disease in a British cohort. Gut 2006;55:969-72.
22. Oostenbrug LE, Drenth JP, de Jong DJ, et al. Association between Toll-like receptor 4 and inflammatory bowel disease. Inflamm Bowel Dis 2005;11:567-75.
23. van Bodegraven AA, Curley CR, Hunt KA, et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006;131:1768-74.
24. Matter K, Aijaz S, Tsapara A, et al. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005;17:453-8.
25. The International HapMapConsortium. The International HapMap Project. Nature 2003;426:789-96.
26. Berkes J, Viswanathan VK, Savkovic SD, et al. Intestinal epithelial responses to enteric pathogens: effects on the tight junction barrier, ion transport, and inflammation. Gut 2003;52:439-51.
27. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial barrier in intestinal disease. Lab Invest 2004;84:282- 91.
28. Drago S, El Asmar R, Di Pierro M, et al. Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 2006;41:408-19.
29. Sander GR, Cummins AG, Henshall T, et al. Rapid disruption of intestinal barrier function by gliadin involves altered expression of apical junctional proteins. FEBS Lett 2005;579:4851-5.
30. Rajasekaran SA, Palmer LG, Moon SY, et al. Na,K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in epithelial cells. Mol Biol Cell 2001;12:3717-32.
31. Takakuwa R, Kokai Y, Kojima T, et al. Uncoupling of gate and fence functions of MDCK cells by the actin-depolymerizing reagent mycalolide B. Exp Cell Res 2000;257:238-44.
32. van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827-9.
33. Amundsen SS, Monsuur AJ, Wapenaar MC, et al. Association analysis of MYO9B gene polymorphisms with celiac disease in a Swedish/Norwegian cohort. Hum Immunol 2006;67:341-5.
34. Giordano M, Marano C, Mellai M, et al. A family-based study does not confirm the association of MYO9B with celiac disease in the Italian population. Genes Immun 2006;7:606-8.
35. Ho GT, Soranzo N, Nimmo ER, et al. ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet 2006;15:797-805.
36. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet 2004;36:476-80.
37. Daly MJ, Pearce AV, Farwell L, et al. Association of DLG5 R30Q variant with inflammatory bowel disease. Eur J Hum Genet 2005;13:835-9.
38. Friedrichs F, Stoll M. Role of discs large homolog 5. World J Gastroenterol 2006;12:3651-6.
39. Tremelling M, Waller S, Bredin F, et al. Genetic variants in TNF-alpha but not DLG5 are associated with inflammatory bowel disease in a large United Kingdom cohort. Inflamm Bowel Dis 2006;12:178-84.
40. Medici V, Mascheretti S, Croucher PJ, et al. Extreme heterogeneity in CARD15 and DLG5 Crohn disease-associated polymorphisms between German and Norwegian populations. Eur J Hum Genet 2006;14:459-68.